mortality/aging
• mice display higher mortality, with no mice surviving past 20 weeks
|
cardiovascular system
• cardiomyocytes are enlarged and cardiomyocyte nuclei are enlarged
|
• mice develop enlarged hearts
• however, hearts are normal at 4-8 weeks of age
|
• cardiomyocytes are enlarged and expression of hypertrophic marker genes are elevated
|
• ventricular walls are only moderately thicker at 10 weeks of age
|
• dilated hearts show mild fibrosis
|
• mice develop dilated cardiomyopathy
|
• fractional shortening is reduced, indicating contractile dysfunction
|
• echocardiography at 8 weeks of age indicates increased systolic dimensions and a tendency towards increased diastolic diameters of the left-ventricular chamber
|
• ECG-analysis indicates atrial fibrillation in 5 of 8 mice
|
• mice frequently exhibit premature ventricular beats
|
• in a severe case, spontaneous pauses in contraction lasting longer than 5 seconds are seen, most likely due to sinoatrial block
|
• mice exhibit symptoms indicative of congestive heart failure
|
homeostasis/metabolism
• atria frequently contain organized thrombi
|
muscle
• cardiomyocytes are enlarged and cardiomyocyte nuclei are enlarged
|
• mice develop dilated cardiomyopathy
|
• fractional shortening is reduced, indicating contractile dysfunction
|
growth/size/body
• mice develop enlarged hearts
• however, hearts are normal at 4-8 weeks of age
|
• cardiomyocytes are enlarged and expression of hypertrophic marker genes are elevated
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:263774 |